This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Massachusetts. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Artem Kutikov: Innovator in Tissue Engineering
Introduction
Artem Kutikov is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of tissue engineering, particularly through his innovative work on chemically modified cellulose fibrous meshes.
Latest Patents
Kutikov holds a patent for "Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds." This invention involves the fabrication of cellulose and sulfated cellulose fibrous meshes that exhibit robust structural and mechanical integrity in water. The sulfated fibrous mesh demonstrates a higher retention capacity for human recombinant bone morphogenetic protein-2 compared to the cellulose mesh. Notably, the retained proteins remain biologically active for at least 7 days. Additionally, the sulfated fibrous mesh supports the attachment and osteogenic differentiation of rat bone marrow stromal cells without the need for osteogenic growth factors. These properties make the sulfated cellulose fibrous mesh a promising candidate for bone tissue engineering scaffolds.
Career Highlights
Kutikov is affiliated with the University of Massachusetts, where he continues to advance research in tissue engineering. His work has garnered attention for its potential applications in regenerative medicine.
Collaborations
Some of Kutikov's coworkers include Jie Song and Tera Marie Filion Potts, who contribute to the collaborative research efforts at the University of Massachusetts.
Conclusion
Artem Kutikov's innovative work in developing chemically modified cellulose fibrous meshes represents a significant advancement in tissue engineering. His contributions have the potential to impact the field of regenerative medicine positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
